Clinical Trials Directory

Trials / Completed

CompletedNCT03479697

HIRREM for Stage 1 Primary Hypertension

High-Resolution, Relational, Resonance-Based, Electroencephalic Mirroring (HIRREM) for Stage 1 Primary Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine that effects of an intervention called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), on Stage 1 Primary Hypertension (systolic BP 130-139, and/or diastolic BP 80-89).

Detailed description

The purpose of this research study is to determine the effects of a technique called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM®), for hypertension. HIRREM uses scalp sensors to monitor brain electrical activity, and computer software algorithms translate selected brain frequencies into audible tones in real time. Those tones are reflected back to participants via ear buds in as little as four to eight milliseconds, providing the brain an opportunity for self-adjustment of its electrical pattern. This study will compare acoustic stimulation linked to brainwave activity (HIRREM, along with continued current care, HCC), with continued current clinical care alone (CCC). Both groups will continue their other current care throughout, including non-pharmacological, and lifestyle modification therapies.

Conditions

Interventions

TypeNameDescription
DEVICEHIRREMTechnology
OTHERContinued Current CareContinue their current clinical care.

Timeline

Start date
2018-08-08
Primary completion
2020-11-13
Completion
2020-11-13
First posted
2018-03-27
Last updated
2023-04-20
Results posted
2023-04-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03479697. Inclusion in this directory is not an endorsement.